These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 1542097)

  • 1. Class III antiarrhythmic activity of novel substituted 4-[(methylsulfonyl)amino]benzamides and sulfonamides.
    Ellingboe JW; Spinelli W; Winkley MW; Nguyen TT; Parsons RW; Moubarak IF; Kitzen JM; Von Engen D; Bagli JF
    J Med Chem; 1992 Feb; 35(4):705-16. PubMed ID: 1542097
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of WAY-123,398, a new class III antiarrhythmic agent, on cardiac refractoriness and ventricular fibrillation threshold in anesthetized dogs: a comparison with UK-68798, E-4031, and dl-sotalol.
    Spinelli W; Parsons RW; Colatsky TJ
    J Cardiovasc Pharmacol; 1992 Dec; 20(6):913-22. PubMed ID: 1282594
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cellular electrophysiology of WAY-123,398, a new class III antiarrhythmic agent: specificity of IK block and lack of reverse use dependence in cat ventricular myocytes.
    Spinelli W; Moubarak IF; Parsons RW; Colatsky TJ
    Cardiovasc Res; 1993 Sep; 27(9):1580-91. PubMed ID: 8287434
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rational design of 4-[(methylsulfonyl)amino]benzamides as class III antiarrhythmic agents.
    Lumma WC; Wohl RA; Davey DD; Argentieri TM; DeVita RJ; Gomez RP; Jain VK; Marisca AJ; Morgan TK; Reiser HJ
    J Med Chem; 1987 May; 30(5):755-8. PubMed ID: 3572962
    [No Abstract]   [Full Text] [Related]  

  • 5. Synthesis and selective class III antiarrhythmic activity of novel N-heteroaralkyl-substituted 1-(aryloxy)-2-propanolamine and related propylamine derivatives.
    Butera JA; Spinelli W; Anantharaman V; Marcopulos N; Parsons RW; Moubarak IF; Cullinan C; Bagli JF
    J Med Chem; 1991 Nov; 34(11):3212-28. PubMed ID: 1956040
    [TBL] [Abstract][Full Text] [Related]  

  • 6. UK-68,798: a novel, potent and highly selective class III antiarrhythmic agent which blocks potassium channels in cardiac cells.
    Gwilt M; Arrowsmith JE; Blackburn KJ; Burges RA; Cross PE; Dalrymple HW; Higgins AJ
    J Pharmacol Exp Ther; 1991 Jan; 256(1):318-24. PubMed ID: 1988662
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis, cardiac electrophysiology, and beta-blocking activity of novel arylpiperazines with potential as class II/III antiarrhythmic agents.
    Phillips GB; Morgan TK; Lumma WC; Gomez RP; Lind JM; Lis R; Argentieri T; Sullivan ME
    J Med Chem; 1992 Feb; 35(4):743-50. PubMed ID: 1347318
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and antiarrhythmic activity of novel 3-alkyl-1-[omega-[4-[(alkylsulfonyl)amino]phenyl]-omega- hydroxyalkyl]-1H-imidazolium salts and related compounds.
    Lis R; Morgan TK; DeVita RJ; Davey DD; Lumma WC; Wohl RA; Diamond J; Wong SS; Sullivan ME
    J Med Chem; 1987 Apr; 30(4):696-704. PubMed ID: 3560162
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and antiarrhythmic activity of novel 3-alkyl-1-[omega-[4-[(alkylsulfonyl)amino]phenyl]-omega- hydroxyalkyl]-1H-imidazolium salts and related compounds. 2.
    Lis R; Davey DD; Morgan TK; Lumma WC; Wohl RA; Jain VK; Wan CN; Argentieri TM; Sullivan ME; Cantor EH
    J Med Chem; 1987 Dec; 30(12):2303-9. PubMed ID: 3681900
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel antiarrhythmic compounds with combined class IB and class III mode of action.
    Mátyus P; Varga I; Rettegi T; Simay A; Kállay N; Károlyházy L; Kocsis A; Varró A; Pénzes I; Papp JG
    Curr Med Chem; 2004 Jan; 11(1):61-9. PubMed ID: 14754426
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and cardiac electrophysiological activity of N-substituted-4-(1H-imidazol-1-yl)benzamides--new selective class III agents.
    Morgan TK; Lis R; Lumma WC; Nickisch K; Wohl RA; Phillips GB; Gomez RP; Lampe JW; Di Meo SV; Marisca AJ
    J Med Chem; 1990 Apr; 33(4):1091-7. PubMed ID: 2319557
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multiple cellular electrophysiological effects of a novel antiarrhythmic furoquinoline derivative HA-7 [N-benzyl-7-methoxy-2,3,4,9-tetrahydrofuro[2,3-b]quinoline-3,4-dione] in guinea pig cardiac preparations.
    Chang GJ; Su MJ; Kuo SC; Lin TP; Lee YS
    J Pharmacol Exp Ther; 2006 Jan; 316(1):380-91. PubMed ID: 16174797
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Electrophysiological characterization of BRL-32872 in canine Purkinje fiber and ventricular muscle. Effect on early after-depolarizations and repolarization dispersion.
    Faivre JF; Forest MC; Gout B; Bril A
    Eur J Pharmacol; 1999 Oct; 383(2):215-22. PubMed ID: 10585537
    [TBL] [Abstract][Full Text] [Related]  

  • 14. N-[(omega-amino-1-hydroxyalkyl)phenyl]methanesulfonamide derivatives with class III antiarrhythmic activity.
    Hester JB; Gibson JK; Cimini MG; Emmert DE; Locker PK; Perricone SC; Skaletzky LL; Sykes JK; West BE
    J Med Chem; 1991 Jan; 34(1):308-15. PubMed ID: 1992131
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and biological action of the aminotetrahydroisoquinocarbazoles and related compounds: a new class of compounds with antiarrhythmic activity.
    Shimoji Y; Tomita K; Hashimoto T; Saito F; Morisawa Y; Mizuno H; Yorikane R; Koike H
    J Med Chem; 1992 Mar; 35(5):816-22. PubMed ID: 1548673
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Frequency-dependent electrophysiological effect of ibutilide on human atrium and ventricle.
    Oshikawa N; Watanabe I; Masaki R; Shindo A; Kojima T; Saito S; Ozawa Y; Kanmatsuse K
    J Interv Card Electrophysiol; 2001 Mar; 5(1):81-7. PubMed ID: 11248779
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Electrophysiological effects of ACC-9358, a novel class I antiarrhythmic agent, on isolated canine Purkinje fibers and ventricular muscle.
    Brown BS
    J Pharmacol Exp Ther; 1989 Feb; 248(2):552-8. PubMed ID: 2918472
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Electrophysiological actions of mexiletine on isolated rabbit atria and canine ventricular muscle and purkinje fibres.
    Yamaguchi I; Singh BN; Mandel WJ
    Cardiovasc Res; 1979 May; 13(5):288-96. PubMed ID: 476749
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanisms of arrhythmias and of antiarrythmic activity, with special reference to mexiletine.
    Carmeliet E
    Acta Cardiol Suppl; 1980; (25):5-25. PubMed ID: 6246694
    [No Abstract]   [Full Text] [Related]  

  • 20. Effects of aprindine and lidocaine on transmembrane potentials and radioactive K efflux in different cardiac tissues.
    Carmeliet E; Verdonck F
    Acta Cardiol; 1974; Suppl 18():73-90. PubMed ID: 4547403
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.